Quince Therapeutics, Inc.QNCXNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank43
3Y CAGR-4.9%
5Y CAGR-1.6%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
-4.9%/yr
vs +103.8%/yr prior
5Y CAGR
-1.6%/yr
Recent deceleration
Acceleration
-108.8pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $114.48M | -36.5% |
| 2023 | $180.20M | +73.4% |
| 2022 | $103.91M | -22.0% |
| 2021 | $133.23M | -29.7% |
| 2020 | $189.47M | +52.3% |
| 2019 | $124.37M | +70.7% |
| 2018 | $72.88M | +844.3% |
| 2017 | $7.72M | - |